PlainPharmaWatch

CMS Open Payments · Tool

Compare Pharma Companies

Select two pharmaceutical companies to compare their CMS Open Payments data side by side, total payments, recipient counts, payment types, and more. Data from Program Year 2024.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

This tool compares any two of the 1,925 pharmaceutical companies in CMS Open Payments Program Year 2024 side by side, total payments, payment-type mix, and top general-payment recipients. Select two companies below; the comparison is generated live from CMS-reported figures, never estimated.

Select Two Companies

vs

How to Use This Tool

1

Select Two Companies

Choose any two pharmaceutical or medical-device companies from the alphabetized CMS Open Payments corpus.

2

Compare Side by Side

View total payments, transaction counts, recipient counts, payment type breakdowns, and top recipients in a clear side-by-side layout.

3

Explore Full Profiles

Click through to individual company profiles for complete payment type breakdowns, all recipients, and industry context from CMS Open Payments.

Popular Company Pairs

Novartis Pharmaceuticals Corporation vs Pfizer Inc. ModernaTX, Inc. vs Eli Lilly and Company Abbvie Inc. vs Merck Sharp & Dohme LLC AstraZeneca Pharmaceuticals LP vs Genentech, Inc. Midmark Corporation vs Janssen Research & Development, LLC Amgen Inc. vs E.R. Squibb & Sons, L.L.C.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Compiled from official public sources by the editorial team.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.